PHARMACEUTICAL INDUSTRY :
Process Validation
  Client:   A top "10" global diagnostic and pharmaceutical firm, instantly recognizable, that includes prescription and diagnostic pharmaceuticals.
     
  Problem:   The client was under sanctions imposed by the FDA, with a commitment to evaluate the process and analytical validation of diagnostic products and devices. Tunnell and the client agreed that the evaluation would include assessment of whether: 1) correct critical process and analytical parameters had been identified and addressed, 2) critical specifications were correct and justified, 3) the validations were executed and documented correctly and, 4) the validations met and would continue to meet regulatory and industry validation standards. Tunnell and the client agreed that identified deficiencies in the assessments and commitments for future validation activities would be addressed via co-authored protocols.
     
  Approach:   Tunnell worked in conjunction with client personnel to create, resource, and successfully execute a comprehensive assessment and gap analysis project. The assessment was designed to: 1) provide a comprehensive history file (from existing documentation) to support the product and specifications, 2) provide constructive changes to existing validation reports and include written protocols (if necessary) to correct or strengthen compliance to a validation program, 3) provide written protocols to ensure continued compliance, and 4) provide the methodology to determine, monitor and understand key product attributes in the future.
     
  Results:  
  • Provided the client with a comprehensive validation assessment, with both high-level actions and detailed, checklist driven tasks that were required to correct deficiencies and/ or obtain a satisfactory compliance level.
  • Provided the client with a written protocol to ensure the validation initiative would be carried forward (3-year plan) and would provide confidence that the process / methodology continued to meet product specifications and qualities.
  •        
       
    Return to Project Briefs View next Project Brief >>
     
    About Us | Capabilities/Practices | Projects/Results | Our People |
    News/Events | Publications | Clients | Careers | Contact Us | Home